A mouse model for functional dissection of TAB1 O-GlcNAcylation

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• O-GlcNAcylation is a critical posttranslational modification impacting numerous cellular processes.
• Understanding specific O-GlcNAc sites and their physiological roles is limited by a lack of appropriate in vivo models.
• TAB1 (TGF-β activated kinase-1 binding protein-1) has a known O-GlcNAc site influencing cytokine release via TAK1 signaling.

Purpose of the Study:

• To generate and characterize a mouse model lacking O-GlcNAcylation on TAB1.
• To investigate the in vivo consequences of losing the TAB1 O-GlcNAc modification.
• To establish a tool for studying TAB1 O-GlcNAcylation in inflammatory responses.

Main Methods:

• Generation of a constitutive knock-in mouse model (Tab1 S393A).
• The mutation ablates the single identified O-GlcNAcylation site on TAB1.
• Phenotypic analysis of Tab1 mutant mice.

Main Results:

• Tab1 mutant mice are viable and exhibit no overt phenotypic abnormalities.
• Loss of TAB1 O-GlcNAcylation does not affect TAB1 protein levels.
• The interaction between TAB1 and TAK1 remains unaffected by the mutation.

Conclusions:

• Homozygous Tab1 mutant mice are healthy, demonstrating the viability of ablating this specific O-GlcNAc site.
• This mouse model provides a valuable resource for dissecting the in vivo role of TAB1 O-GlcNAcylation in biological processes, particularly inflammation.
• Further research can now explore the nuanced functions of TAB1 O-GlcNAcylation within a whole organism context.